Quick Answer
cbdMD, Inc. reported Cash And Cash Equivalents At Carrying Value of $2.26 million for the year ending 2025.
- cbdMD, Inc. showed a decrease of -7.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from cbdMD, Inc.'s annual report (Form 10-K), filed with the SEC on December 19, 2025.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: $1.12 million | Q1 2017: $354.5 thousand | Q2 2017: $398.4 thousand | Q4 2017: $8.82 million | Q1 2018: $6.71 million | Q2 2018: $5.42 million | Q4 2018: $8.03 million | Q1 2019: $4.64 million | Q2 2019: $11.63 million | Q4 2019: $3.66 million | Q1 2020: $14.84 million | Q2 2020: $15.01 million | Q3 2020: $14.82 million | Q4 2020: $28.76 million | Q1 2021: $23.71 million | Q2 2021: $18.98 million | Q4 2021: $19.70 million | Q1 2022: $13.34 million | Q2 2022: $9.55 million | Q4 2022: $3.35 million | Q1 2023: $1.72 million | Q2 2023: $2.85 million | Q4 2023: $1.50 million | Q1 2024: $2.11 million | Q2 2024: $2.40 million | Q4 2024: $1.97 million | Q1 2025: $1.77 million | Q2 2025: $1.06 million | Q3 2025: $2.26 million | Q4 2025: $3.39 million.
- Over the full 11 years of available data (2015 to 2025), cbdMD, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 313.8%.
- Historical annual values: Fiscal year 2025: $2.26 million | Fiscal year 2024: $2.45 million | Fiscal year 2023: $1.80 million | Fiscal year 2022: $6.72 million | Fiscal year 2021: $26.41 million | Fiscal year 2020: $14.82 million | Fiscal year 2019: $4.69 million | Fiscal year 2018: $4.28 million | Fiscal year 2017: $284.2 thousand | Fiscal year 2016: $34.3 thousand | Fiscal year 2015: $546.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: